These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 16489847)

  • 21. Non-Vitamin K Antagonist Oral Anticoagulants and Antiplatelet Therapy for Stroke Prevention in Patients With Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials.
    Kumar S; Danik SB; Altman RK; Barrett CD; Lip GY; Chatterjee S; Roubin GS; Natale A; Danik JS
    Cardiol Rev; 2016; 24(5):218-23. PubMed ID: 26274538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mortality and rate of stroke or embolism in atrial fibrillation during long-term follow-up in the embolism in left atrial thrombi (ELAT) study.
    Stöllberger C; Chnupa P; Abzieher C; Länger T; Finsterer J; Klem I; Hartl E; Wehinger C; Schneider B
    Clin Cardiol; 2004 Jan; 27(1):40-6. PubMed ID: 14743856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of warfarin versus aspirin on the incidence of new thromboembolic stroke in older persons with chronic atrial fibrillation and abnormal and normal left ventricular ejection fraction.
    Aronow WS; Ahn C; Kronzon I; Gutstein H
    Am J Cardiol; 2000 Apr; 85(8):1033-5. PubMed ID: 10760353
    [No Abstract]   [Full Text] [Related]  

  • 24. Bleeding Risk and Antithrombotic Strategy in Patients With Sinus Rhythm and Heart Failure With Reduced Ejection Fraction Treated With Warfarin or Aspirin.
    Ye S; Cheng B; Lip GY; Buchsbaum R; Sacco RL; Levin B; Di Tullio MR; Qian M; Mann DL; Pullicino PM; Freudenberger RS; Teerlink JR; Mohr JP; Graham S; Labovitz AJ; Estol CJ; Lok DJ; Ponikowski P; Anker SD; Thompson JL; Homma S;
    Am J Cardiol; 2015 Sep; 116(6):904-12. PubMed ID: 26189039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes in a Warfarin-Treated Population With Atrial Fibrillation.
    Björck F; Renlund H; Lip GY; Wester P; Svensson PJ; Själander A
    JAMA Cardiol; 2016 May; 1(2):172-80. PubMed ID: 27437888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: evidence for gender differences in the studies of left ventricular dysfunction trials.
    Dries DL; Rosenberg YD; Waclawiw MA; Domanski MJ
    J Am Coll Cardiol; 1997 Apr; 29(5):1074-80. PubMed ID: 9120162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What do we know about anticoagulation in patients with heart failure?
    Ahnert AM; Freudenberger RS
    Curr Opin Cardiol; 2008 May; 23(3):228-32. PubMed ID: 18382211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Atrial fibrillation and stroke].
    Mattle HP; Schwerzmann M; Seiler Ch
    Ther Umsch; 2003 Sep; 60(9):527-34. PubMed ID: 14579621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Anticoagulant therapy in patients with dilated cardiomyopathy].
    Gensini GF; Rostagno C
    Ann Ital Med Int; 1998; 13(4):227-32. PubMed ID: 10349204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
    Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
    Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial.
    Massie BM; Collins JF; Ammon SE; Armstrong PW; Cleland JG; Ezekowitz M; Jafri SM; Krol WF; O'Connor CM; Schulman KA; Teo K; Warren SR;
    Circulation; 2009 Mar; 119(12):1616-24. PubMed ID: 19289640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stroke in heart failure in sinus rhythm: the Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial.
    Pullicino PM; Thompson JL; Sacco RL; Sanford AR; Qian M; Teerlink JR; Haddad H; Diek M; Freudenberger RS; Labovitz AJ; Di Tullio MR; Lok DJ; Ponikowski P; Anker SD; Graham S; Mann DL; Mohr JP; Homma S;
    Cerebrovasc Dis; 2013; 36(1):74-8. PubMed ID: 23921215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticoagulation and heart failure.
    Graham SP
    Curr Cardiol Rep; 2001 Jan; 3(1):72-7. PubMed ID: 11139802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticoagulation therapy in patients with heart failure due to systolic dysfunction and sinus rhythm: analysis of REDINSCOR registry.
    Avellana P; Segovia J; Ferrero A; Vázquez R; Brugada J; Borrás X; Alonso-Pulpón L; Cinca J
    Rev Esp Cardiol (Engl Ed); 2012 Aug; 65(8):705-12. PubMed ID: 22464104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolving strategies to prevent stroke and thromboembolism in nonvalvular atrial fibrillation.
    Hussein A; Saliba W; Wazni OM
    Cleve Clin J Med; 2015 Dec; 82(12 Suppl 2):S11-6. PubMed ID: 26694887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral anticoagulation with warfarin for patients with left ventricular systolic dysfunction.
    Snowden S; Silus L
    Cardiol Rev; 2011; 19(1):36-40. PubMed ID: 21135601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heart Failure Severity and Quality of Warfarin Anticoagulation Control (From the WARCEF Trial).
    Lee TC; Qian M; Lip GYH; Di Tullio MR; Graham S; Mann DL; Nakanishi K; Teerlink JR; Freudenberger RS; Sacco RL; Mohr JP; Labovitz AJ; Ponikowski P; Lok DJ; Estol C; Anker SD; Pullicino PM; Buchsbaum R; Levin B; Thompson JLP; Homma S; Ye S;
    Am J Cardiol; 2018 Sep; 122(5):821-827. PubMed ID: 30037426
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices.
    Savelieva I; Bajpai A; Camm AJ
    Ann Med; 2007; 39(5):371-91. PubMed ID: 17701479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atrial fibrillation and anticoagulation.
    Garnier LF; Rouesnel P; Espitalier F
    Arch Mal Coeur Vaiss; 2004 Oct; 97(10):1001-5. PubMed ID: 16008178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].
    Selçuk H; Selçuk MT; Maden O
    Anadolu Kardiyol Derg; 2007 Mar; 7(1):54-8. PubMed ID: 17347079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.